Global Female Infertility Medications Supply, Demand and Key Producers, 2023-2029

January 2023 | 98 pages | ID: G003D5DA70C9EN
GlobalInfoResearch

Abstracts

Infertility Drugs are drugs which enhance reproductive fertility. For women, Infertility Drugs is used to stimulate follicle development of the ovary. Agents that enhance ovarian activity can be classified as either Gonadotropin releasing hormone, Estrogen antagonists or Gonadotropins.

This report studies the global Female Infertility Medications demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Female Infertility Medications, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Female Infertility Medications that contribute to its increasing demand across many markets.

The global Female Infertility Medications market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Highlights and key features of the study

Global Female Infertility Medications total market, 2018-2029, (USD Million)

Global Female Infertility Medications total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Female Infertility Medications total market, key domestic companies and share, (USD Million)

Global Female Infertility Medications revenue by player and market share 2018-2023, (USD Million)

Global Female Infertility Medications total market by Type, CAGR, 2018-2029, (USD Million)

Global Female Infertility Medications total market by Channel, CAGR, 2018-2029, (USD Million)

This reports profiles major players in the global Female Infertility Medications market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Ferring, MSD, LIVZON, Abbott and Bayer Zydus Pharma, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Female Infertility Medications market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Channel. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Female Infertility Medications Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global Female Infertility Medications Market, Segmentation by Type

• Gonadotropins
• Aromatase Inhibitors
• Selective Estrogen Receptor Modulators (SERMs)
• Dopamine Agonists
• Others

Global Female Infertility Medications Market, Segmentation by Channel

• Hospital Pharmacy
• Specialty & Retail Pharmacy
• Online Pharmacy

Companies Profiled:

• Merck
• Ferring
• MSD
• LIVZON
• Abbott
• Bayer Zydus Pharma

Key Questions Answered

1. How big is the global Female Infertility Medications market?

2. What is the demand of the global Female Infertility Medications market?

3. What is the year over year growth of the global Female Infertility Medications market?

4. What is the total value of the global Female Infertility Medications market?

5. Who are the major players in the global Female Infertility Medications market?

6. What are the growth factors driving the market demand?

Contents

1 SUPPLY SUMMARY

1.1 Female Infertility Medications Introduction
1.2 World Female Infertility Medications Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Female Infertility Medications Total Market by Region (by Headquarter Location)
  1.3.1 World Female Infertility Medications Market Size by Region (2018-2029), (by Headquarter Location)
  1.3.2 United States Female Infertility Medications Market Size (2018-2029)
  1.3.3 China Female Infertility Medications Market Size (2018-2029)
  1.3.4 Europe Female Infertility Medications Market Size (2018-2029)
  1.3.5 Japan Female Infertility Medications Market Size (2018-2029)
  1.3.6 South Korea Female Infertility Medications Market Size (2018-2029)
  1.3.7 ASEAN Female Infertility Medications Market Size (2018-2029)
  1.3.8 India Female Infertility Medications Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Female Infertility Medications Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Female Infertility Medications Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Female Infertility Medications Consumption Value (2018-2029)
2.2 World Female Infertility Medications Consumption Value by Region
  2.2.1 World Female Infertility Medications Consumption Value by Region (2018-2023)
  2.2.2 World Female Infertility Medications Consumption Value Forecast by Region (2024-2029)
2.3 United States Female Infertility Medications Consumption Value (2018-2029)
2.4 China Female Infertility Medications Consumption Value (2018-2029)
2.5 Europe Female Infertility Medications Consumption Value (2018-2029)
2.6 Japan Female Infertility Medications Consumption Value (2018-2029)
2.7 South Korea Female Infertility Medications Consumption Value (2018-2029)
2.8 ASEAN Female Infertility Medications Consumption Value (2018-2029)
2.9 India Female Infertility Medications Consumption Value (2018-2029)

3 WORLD FEMALE INFERTILITY MEDICATIONS COMPANIES COMPETITIVE ANALYSIS

3.1 World Female Infertility Medications Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Female Infertility Medications Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Female Infertility Medications in 2022
  3.2.3 Global Concentration Ratios (CR8) for Female Infertility Medications in 2022
3.3 Female Infertility Medications Company Evaluation Quadrant
3.4 Female Infertility Medications Market: Overall Company Footprint Analysis
  3.4.1 Female Infertility Medications Market: Region Footprint
  3.4.2 Female Infertility Medications Market: Company Product Type Footprint
  3.4.3 Female Infertility Medications Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Female Infertility Medications Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Female Infertility Medications Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
  4.1.2 United States VS China: Female Infertility Medications Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Female Infertility Medications Consumption Value Comparison
  4.2.1 United States VS China: Female Infertility Medications Consumption Value Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Female Infertility Medications Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Female Infertility Medications Companies and Market Share, 2018-2023
  4.3.1 United States Based Female Infertility Medications Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Female Infertility Medications Revenue, (2018-2023)
4.4 China Based Companies Female Infertility Medications Revenue and Market Share, 2018-2023
  4.4.1 China Based Female Infertility Medications Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Female Infertility Medications Revenue, (2018-2023)
4.5 Rest of World Based Female Infertility Medications Companies and Market Share, 2018-2023
  4.5.1 Rest of World Based Female Infertility Medications Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies Female Infertility Medications Revenue, (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Female Infertility Medications Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Gonadotropins
  5.2.2 Aromatase Inhibitors
  5.2.3 Selective Estrogen Receptor Modulators (SERMs)
  5.2.4 Dopamine Agonists
  5.2.5 Others
5.3 Market Segment by Type
  5.3.1 World Female Infertility Medications Market Size by Type (2018-2023)
  5.3.2 World Female Infertility Medications Market Size by Type (2024-2029)
  5.3.3 World Female Infertility Medications Market Size Market Share by Type (2018-2029)

6 MARKET ANALYSIS BY CHANNEL

6.1 World Female Infertility Medications Market Size Overview by Channel: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Channel
  6.2.1 Hospital Pharmacy
  6.2.2 Specialty & Retail Pharmacy
  6.2.3 Online Pharmacy
6.3 Market Segment by Channel
  6.3.1 World Female Infertility Medications Market Size by Channel (2018-2023)
  6.3.2 World Female Infertility Medications Market Size by Channel (2024-2029)
  6.3.3 World Female Infertility Medications Market Size by Channel (2018-2029)

7 COMPANY PROFILES

7.1 Merck
  7.1.1 Merck Details
  7.1.2 Merck Major Business
  7.1.3 Merck Female Infertility Medications Product and Services
  7.1.4 Merck Female Infertility Medications Revenue, Gross Margin and Market Share (2018-2023)
  7.1.5 Merck Recent Developments/Updates
  7.1.6 Merck Competitive Strengths & Weaknesses
7.2 Ferring
  7.2.1 Ferring Details
  7.2.2 Ferring Major Business
  7.2.3 Ferring Female Infertility Medications Product and Services
  7.2.4 Ferring Female Infertility Medications Revenue, Gross Margin and Market Share (2018-2023)
  7.2.5 Ferring Recent Developments/Updates
  7.2.6 Ferring Competitive Strengths & Weaknesses
7.3 MSD
  7.3.1 MSD Details
  7.3.2 MSD Major Business
  7.3.3 MSD Female Infertility Medications Product and Services
  7.3.4 MSD Female Infertility Medications Revenue, Gross Margin and Market Share (2018-2023)
  7.3.5 MSD Recent Developments/Updates
  7.3.6 MSD Competitive Strengths & Weaknesses
7.4 LIVZON
  7.4.1 LIVZON Details
  7.4.2 LIVZON Major Business
  7.4.3 LIVZON Female Infertility Medications Product and Services
  7.4.4 LIVZON Female Infertility Medications Revenue, Gross Margin and Market Share (2018-2023)
  7.4.5 LIVZON Recent Developments/Updates
  7.4.6 LIVZON Competitive Strengths & Weaknesses
7.5 Abbott
  7.5.1 Abbott Details
  7.5.2 Abbott Major Business
  7.5.3 Abbott Female Infertility Medications Product and Services
  7.5.4 Abbott Female Infertility Medications Revenue, Gross Margin and Market Share (2018-2023)
  7.5.5 Abbott Recent Developments/Updates
  7.5.6 Abbott Competitive Strengths & Weaknesses
7.6 Bayer Zydus Pharma
  7.6.1 Bayer Zydus Pharma Details
  7.6.2 Bayer Zydus Pharma Major Business
  7.6.3 Bayer Zydus Pharma Female Infertility Medications Product and Services
  7.6.4 Bayer Zydus Pharma Female Infertility Medications Revenue, Gross Margin and Market Share (2018-2023)
  7.6.5 Bayer Zydus Pharma Recent Developments/Updates
  7.6.6 Bayer Zydus Pharma Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Female Infertility Medications Industry Chain
8.2 Female Infertility Medications Upstream Analysis
8.3 Female Infertility Medications Midstream Analysis
8.4 Female Infertility Medications Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Female Infertility Medications Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Female Infertility Medications Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Female Infertility Medications Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Female Infertility Medications Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Female Infertility Medications Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Female Infertility Medications Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Female Infertility Medications Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Female Infertility Medications Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Female Infertility Medications Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Female Infertility Medications Players in 2022
Table 12. World Female Infertility Medications Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Female Infertility Medications Company Evaluation Quadrant
Table 14. Head Office of Key Female Infertility Medications Player
Table 15. Female Infertility Medications Market: Company Product Type Footprint
Table 16. Female Infertility Medications Market: Company Product Application Footprint
Table 17. Female Infertility Medications Mergers & Acquisitions Activity
Table 18. United States VS China Female Infertility Medications Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Female Infertility Medications Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Female Infertility Medications Companies, Headquarters (States, Country)
Table 21. United States Based Companies Female Infertility Medications Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Female Infertility Medications Revenue Market Share (2018-2023)
Table 23. China Based Female Infertility Medications Companies, Headquarters (Province, Country)
Table 24. China Based Companies Female Infertility Medications Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Female Infertility Medications Revenue Market Share (2018-2023)
Table 26. Rest of World Based Female Infertility Medications Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Female Infertility Medications Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Female Infertility Medications Revenue Market Share (2018-2023)
Table 29. World Female Infertility Medications Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Female Infertility Medications Market Size by Type (2018-2023) & (USD Million)
Table 31. World Female Infertility Medications Market Size by Type (2024-2029) & (USD Million)
Table 32. World Female Infertility Medications Market Size by Channel, (USD Million), 2018 & 2022 & 2029
Table 33. World Female Infertility Medications Market Size by Channel (2018-2023) & (USD Million)
Table 34. World Female Infertility Medications Market Size by Channel (2024-2029) & (USD Million)
Table 35. Merck Basic Information, Area Served and Competitors
Table 36. Merck Major Business
Table 37. Merck Female Infertility Medications Product and Services
Table 38. Merck Female Infertility Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Merck Recent Developments/Updates
Table 40. Merck Competitive Strengths & Weaknesses
Table 41. Ferring Basic Information, Area Served and Competitors
Table 42. Ferring Major Business
Table 43. Ferring Female Infertility Medications Product and Services
Table 44. Ferring Female Infertility Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Ferring Recent Developments/Updates
Table 46. Ferring Competitive Strengths & Weaknesses
Table 47. MSD Basic Information, Area Served and Competitors
Table 48. MSD Major Business
Table 49. MSD Female Infertility Medications Product and Services
Table 50. MSD Female Infertility Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. MSD Recent Developments/Updates
Table 52. MSD Competitive Strengths & Weaknesses
Table 53. LIVZON Basic Information, Area Served and Competitors
Table 54. LIVZON Major Business
Table 55. LIVZON Female Infertility Medications Product and Services
Table 56. LIVZON Female Infertility Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. LIVZON Recent Developments/Updates
Table 58. LIVZON Competitive Strengths & Weaknesses
Table 59. Abbott Basic Information, Area Served and Competitors
Table 60. Abbott Major Business
Table 61. Abbott Female Infertility Medications Product and Services
Table 62. Abbott Female Infertility Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Abbott Recent Developments/Updates
Table 64. Bayer Zydus Pharma Basic Information, Area Served and Competitors
Table 65. Bayer Zydus Pharma Major Business
Table 66. Bayer Zydus Pharma Female Infertility Medications Product and Services
Table 67. Bayer Zydus Pharma Female Infertility Medications Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 68. Global Key Players of Female Infertility Medications Upstream (Raw Materials)
Table 69. Female Infertility Medications Typical Customers

List Of Figures

LIST OF FIGURES

Figure 1. Female Infertility Medications Picture
Figure 2. World Female Infertility Medications Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Female Infertility Medications Total Market Size (2018-2029) & (USD Million)
Figure 4. World Female Infertility Medications Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Female Infertility Medications Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Female Infertility Medications Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Female Infertility Medications Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Female Infertility Medications Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Female Infertility Medications Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Female Infertility Medications Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Female Infertility Medications Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Female Infertility Medications Revenue (2018-2029) & (USD Million)
Figure 13. Female Infertility Medications Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Female Infertility Medications Consumption Value (2018-2029) & (USD Million)
Figure 16. World Female Infertility Medications Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Female Infertility Medications Consumption Value (2018-2029) & (USD Million)
Figure 18. China Female Infertility Medications Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Female Infertility Medications Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Female Infertility Medications Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Female Infertility Medications Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Female Infertility Medications Consumption Value (2018-2029) & (USD Million)
Figure 23. India Female Infertility Medications Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Female Infertility Medications by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Female Infertility Medications Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Female Infertility Medications Markets in 2022
Figure 27. United States VS China: Female Infertility Medications Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Female Infertility Medications Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Female Infertility Medications Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Female Infertility Medications Market Size Market Share by Type in 2022
Figure 31. Gonadotropins
Figure 32. Aromatase Inhibitors
Figure 33. Selective Estrogen Receptor Modulators (SERMs)
Figure 34. Dopamine Agonists
Figure 35. Others
Figure 36. World Female Infertility Medications Market Size Market Share by Type (2018-2029)
Figure 37. World Female Infertility Medications Market Size by Channel, (USD Million), 2018 & 2022 & 2029
Figure 38. World Female Infertility Medications Market Size Market Share by Channel in 2022
Figure 39. Hospital Pharmacy
Figure 40. Specialty & Retail Pharmacy
Figure 41. Online Pharmacy
Figure 42. Female Infertility Medications Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source